9 completed, 8 unknown, 3 terminated, 1 recruiting. 10 Phase 3, 6 Phase 4, 3 Not applicable, 2 Phase 2, 1 Early Phase 1.
Follow Norfloxacin: new trials by email Literature Review of Norfloxacin trials Research Report on Norfloxacin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of Rifaximin vs Norfloxacin for Secondary Prophylaxis of SBP (NORRIF Trial) Rifaximin, Norfloxacin - Spontaneous Bacterial Peritonitis | Not applicable | Unknown | Institute of Liver and Biliary Sciences, India | 280 | 2024-01-05 | 2024-01-10 |
| Comparative Study of Secondary Prophylaxis for SBP Norfloxacin 400 MG, Nitazoxanide 500 MG, Colistin - Spontaneous Bacterial Peritonitis, Cirrhoses, Liver | Phase 4 | Completed | Tanta University | 90 | 2021-03-01 | 2025-02-14 |
| Nitazoxanide in Prevention of Secondary Spontaneous Peritonitis Nitazoxanide, Norfloxacin - Spontaneous Bacterial Peritonitis | Phase 3 | Unknown | Tanta University | 60 | 2021-03-01 | 2021-02-10 |
| Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis Rifaximin, Norfloxacin - Spontaneous Bacterial Peritonitis | Phase 3 | Unknown | Ospedali Riuniti di Foggia | 322 | 2019-11-05 | 2021-02-16 |
| Antibiotic Profile of Pathogenic Bacteria Isolated in Public Hospitals in Northern Jordan ciprofloxacin - Bacterial Infections, Antibiotic Resistant Infection | Completed | Yarmouk University | 24 | 2019-08-01 | 2021-11-04 | |
| Norfloxacin With Itopride Versus Norfloxacin in Secondary Prophylaxis of Spontaneous Bacterial Peritonitis Norfloxacin, Itopride - Spontaneous Bacterial Peritonitis | Phase 3 | Recruiting | Tanta University | 80 | 2018-12-01 | 2019-11-13 |
| Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis GMCSF, Norfloxacin - Spontaneous Bacterial Peritonitis | Not applicable | Completed | Institute of Liver and Biliary Sciences, India | 120 | 2018-07-23 | 2019-10-24 |
| Noroxin Efficacy and Safety Trial Norfloxacin 400 MG - Urinary Tract Infections | Phase 4 | Unknown | OBS Pakistan | 1000 | 2018-05-10 | 2018-04-24 |
| Rifaximin and Norfloxacin for Prevention of SBP in Adults With Decompensated Cirrhosis Rifaximin 550 mg twice a day and Norfloxacin 400 mg once a day - Cirrhosis, Liver | Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 142 | 2016-01-01 | 2018-10-04 |
| Patients Response to Early Switch To Oral:Osteomyelitis Study oral antibiotics, intravenous antibiotics - Osteomyelitis | Early Phase 1 | Terminated | Julio Ramirez | 11 | 2014-03-06 | 2021-04-06 |
| Comparative Study of Rifaximin Versus Norfloxacin in the Secondary Prophylaxis of Spontaneous Bacterial Peritonitis Rifaximin, Norfloxacin - Spontaneous Bacterial Peritonitis, Ascites | Phase 3 | Unknown | Sherief Abd-Elsalam | 100 | 2014-01-01 | 2018-01-09 |
| Comparison in the Treatment of Acute Cystitis Using Cephalosporin and Norfloxacin (CECI) Norfloxacin, Cephalosporins - Cystitis | Phase 3 | Withdrawn | Eurofarma Laboratorios S.A. | 2012-10-01 | 2015-07-27 | |
| Symptomatic Therapy of Uncomplicated Lower Urinary Tract Infections in the Ambulatory Setting. Diclofenac, Norfloxacin - Urinary Tract Infections | Phase 4 | Terminated | Insel Gruppe AG, University Hospital Bern | 253 | 2012-02-01 | 2015-07-09 |
| Norfloxacin Versus Ciprofloxacin for Spontaneous Bacterial Peritonitis (SBP) Prevention Norfloxacin, ciprofloxacin - Adverse Reaction to Other Drugs and Medicines | Phase 4 | Completed | Korea University | 124 | 2011-08-01 | 2016-12-28 |
| Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure Norfloxacin, Placebo - Cirrhosis | Phase 3 | Terminated | Assistance Publique - Hôpitaux de Paris | 291 | 2010-04-01 | 2015-12-09 |
| Role of Probiotics in the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Randomized Placebo Control Trial Probiotics and Placebo, Probiotics and Norfloxacin - Spontaneous Bacterial Peritonitis, Liver Cirrhosis | Phase 2 / Phase 3 | Unknown | All India Institute of Medical Sciences | 250 | 2007-07-01 | 2008-05-15 |
| A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome Norfloxacin, Placebo - Hepatopulmonary Syndrome | Phase 2 | Completed | Unity Health Toronto | 9 | 2006-10-01 | 2016-12-07 |
| Evaluation of Safety & Efficacy of Synbiotic on the Incidence and Recurrence of Spontaneous Bacterial Peritonitis (SBP) in Cirrhotics Norfloxacin + Synbiotic, Norfloxacin + Placebo - Cirrhosis With Ascites | Phase 3 | Completed | Govind Ballabh Pant Hospital | 110 | 2005-04-01 | 2009-07-28 |
| Mortality Control Program for Economically Productive Age Group in Tribal Area of Melghat. Trained village health workers (VHWs) , provided treatment of HTN, diarrhoea, malaria, pneumonia, asthma and COPD by Amlodipine, ORS, Norfloxacin, Chloroquine, Azithromycin, salbutamol rotacaps, Appropriate referral - Hypertension (HTN), Diarrhea | Phase 4 | Completed | MAHAN Trust | 72564 | 2004-01-01 | 2026-02-27 |
| Norfloxacin In The Primary Prophylaxis Of Spontaneous Bacterial Peritonitis Oral norfloxacin - Spontaneous Bacterial Peritonitis, Hepatorenal Syndrome | Phase 4 | Completed | Hospital Clinic of Barcelona | 70 | 2000-09-01 | 2006-08-03 |
Showing 20 of 22. Sign in to see all of them.
Fibrosis (4) · Ascites (3) · Liver Cirrhosis (3) · Urinary Tract Infections (2) · Asthma (1) · Bacterial Infections (1) · Cystitis (1) · Diarrhea (1) · Disease (1) · Esophageal and Gastric Varices (1) · Hepatopulmonary Syndrome (1) · Hepatorenal Syndrome (1) · Hypertension (1) · Hypertension, Portal (1) · Malaria (1)
Tanta University (3) · Govind Ballabh Pant Hospital (2) · Institute of Liver and Biliary Sciences, India (2) · All India Institute of Medical Sciences (1) · Assistance Publique - Hôpitaux de Paris (1) · Bayside Health (1) · Eurofarma Laboratorios S.A. (1) · Hospital Clinic of Barcelona (1) · Insel Gruppe AG, University Hospital Bern (1) · Julio Ramirez (1) · Korea University (1) · MAHAN Trust (1) · OBS Pakistan (1) · Ospedali Riuniti di Foggia (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1)
India (6) · Egypt (3) · Australia (1) · Canada (1) · France (1) · Italy (1) · Jordan (1) · South Korea (1) · Spain (1) · Switzerland (1) · United States (1)
Afaf Younes Mohammed Younes, Msc (1) · Andreas Kronenberg (1) · Asem A Elfert (1) · Ashish R Satav, MBBS, MD (1) · David Seligson, MD (1) · Hyung Joon Yim, M.D., Ph.D. (1) · Julio Ramirez, MD (1) · Marie Faughnan, MD MSc FRCPC (1) · Miquel Navasa, MD (1) · Mona Ahmed Helmy Shehata, Prof. (1) · Raed M Ennab (1) · Sahar M. Elhagar, Professor (1) · Sherief Abd-Elsalam, Ass. Prof. (1)
PMID 37467180, PMID 10453941, PMID 11786970, PMID 1397884, PMID 15276398, PMID 15840453, PMID 17854593, PMID 19588358, PMID 20633946, PMID 20816858, PMID 22530208, PMID 28994123, PMID 29113968, PMID 29427501, PMID 30144431, PMID 30246636, PMID 30920712, PMID 35535057, PMID 39698942, PMID 4902833, PMID 7557868, PMID 8948280, PMID 9764990